FI50421C - Analogiamenetelmä veren liikasokeripitoisuutta alentavien uusien sulfo nyylisemikarbatsidien valmistamiseksi - Google Patents
Analogiamenetelmä veren liikasokeripitoisuutta alentavien uusien sulfo nyylisemikarbatsidien valmistamiseksiInfo
- Publication number
- FI50421C FI50421C FI683354A FI335468A FI50421C FI 50421 C FI50421 C FI 50421C FI 683354 A FI683354 A FI 683354A FI 335468 A FI335468 A FI 335468A FI 50421 C FI50421 C FI 50421C
- Authority
- FI
- Finland
- Prior art keywords
- sulfonylsemicarbazides
- preparation
- new
- blood sugar
- sugar content
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEF0054123 | 1967-11-25 | ||
| US77513868A | 1968-11-12 | 1968-11-12 | |
| US13707771A | 1971-04-23 | 1971-04-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI50421B FI50421B (fi) | 1975-12-01 |
| FI50421C true FI50421C (fi) | 1976-03-10 |
Family
ID=27210550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI683354A FI50421C (fi) | 1967-11-25 | 1968-11-25 | Analogiamenetelmä veren liikasokeripitoisuutta alentavien uusien sulfo nyylisemikarbatsidien valmistamiseksi |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US3668215A (fi) |
| AT (1) | AT282637B (fi) |
| BE (1) | BE724395A (fi) |
| BR (1) | BR6804234D0 (fi) |
| FI (1) | FI50421C (fi) |
| FR (2) | FR1600924A (fi) |
| GB (1) | GB1176310A (fi) |
| IE (1) | IE32579B1 (fi) |
| NL (1) | NL162383C (fi) |
| SE (1) | SE336582B (fi) |
| YU (1) | YU33750B (fi) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3668215A (en) * | 1967-11-25 | 1972-06-06 | Bayer Ag | Aryl-sulphonyl-semicarbazides containing heterocyclic acylamino groups |
| US3907996A (en) * | 1970-08-14 | 1975-09-23 | Boehringer Sohn Ingelheim | Pharmaceutical composition containing a 2-amino-4,5,7,8-tetrahydro-6H-thiazolo or -oxazolo 5,4-D azepine and method of use |
| US3961067A (en) * | 1973-03-07 | 1976-06-01 | Pfizer Inc. | Composition comprising a benzenesulfonylurea hypoglycemic agent and method of treatment |
| PL106114B1 (pl) * | 1976-12-31 | 1979-11-30 | Akad Medyczna | Sposob wytwarzania nowych n-(4-/2-/pirazolo-1-karbonamido/-etylo/-benzenosulfonylo)-mocznikow |
| DE3320583A1 (de) * | 1983-06-08 | 1984-12-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung |
| DE3320582A1 (de) * | 1983-06-08 | 1984-12-13 | Dr. Karl Thomae Gmbh, 7950 Biberach | Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung |
| WO1986005779A1 (en) * | 1985-04-03 | 1986-10-09 | Yamanouchi Pharmaceutical Co., Ltd. | Phenylene derivatives |
| ATE243204T1 (de) * | 1995-08-24 | 2003-07-15 | Basf Ag | Isoxazole- und isothiazole-5-carboxamid derivate, deren herstellung und deren verwendung als herbizide |
| AU2001267878A1 (en) * | 2000-07-05 | 2002-01-14 | Ajinomoto Co. Inc. | Hypoglycemics |
| US8216609B2 (en) * | 2002-08-05 | 2012-07-10 | Torrent Pharmaceuticals Limited | Modified release composition of highly soluble drugs |
| US8268352B2 (en) * | 2002-08-05 | 2012-09-18 | Torrent Pharmaceuticals Limited | Modified release composition for highly soluble drugs |
| US8163956B2 (en) * | 2005-06-13 | 2012-04-24 | Merck Sharp & Dohme Corp. | Inhibitors of GLYT1 transporters |
| CN104163864B (zh) | 2007-03-30 | 2017-08-01 | Ambrx公司 | 经修饰fgf‑21多肽和其用途 |
| CN103159651B (zh) * | 2011-12-14 | 2015-06-17 | 安徽贝克联合制药有限公司 | 磺酰脲胍及其制备方法和用途 |
| PL3412302T3 (pl) | 2014-10-24 | 2021-11-02 | Bristol-Myers Squibb Company | Zmodyfikowane polipeptydy fgf-21 i ich zastosowania |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3668215A (en) * | 1967-11-25 | 1972-06-06 | Bayer Ag | Aryl-sulphonyl-semicarbazides containing heterocyclic acylamino groups |
-
1968
- 1968-11-12 US US775138A patent/US3668215A/en not_active Expired - Lifetime
- 1968-11-13 AT AT1103168A patent/AT282637B/de not_active IP Right Cessation
- 1968-11-14 GB GB54121/68A patent/GB1176310A/en not_active Expired
- 1968-11-15 NL NL6816331.A patent/NL162383C/xx not_active IP Right Cessation
- 1968-11-18 IE IE1381/68A patent/IE32579B1/xx unknown
- 1968-11-21 YU YU2715/68A patent/YU33750B/xx unknown
- 1968-11-22 SE SE15956/68A patent/SE336582B/xx unknown
- 1968-11-22 BR BR204234/68A patent/BR6804234D0/pt unknown
- 1968-11-25 BE BE724395D patent/BE724395A/xx unknown
- 1968-11-25 FR FR1600924D patent/FR1600924A/fr not_active Expired
- 1968-11-25 FI FI683354A patent/FI50421C/fi active
-
1969
- 1969-02-24 FR FR183260A patent/FR8279M/fr not_active Expired
-
1971
- 1971-04-23 US US00137077A patent/US3755587A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US3755587A (en) | 1973-08-28 |
| NL6816331A (fi) | 1969-05-28 |
| NL162383C (nl) | 1980-05-16 |
| GB1176310A (en) | 1970-01-01 |
| FR8279M (fi) | 1970-11-02 |
| YU33750B (en) | 1978-05-15 |
| IE32579L (en) | 1969-05-25 |
| IE32579B1 (en) | 1973-09-19 |
| NL162383B (nl) | 1979-12-17 |
| BE724395A (fi) | 1969-05-27 |
| FI50421B (fi) | 1975-12-01 |
| AT282637B (de) | 1970-07-10 |
| US3668215A (en) | 1972-06-06 |
| FR1600924A (fi) | 1970-08-03 |
| BR6804234D0 (pt) | 1973-02-22 |
| DE1670952A1 (de) | 1970-06-18 |
| SE336582B (fi) | 1971-07-12 |
| YU271568A (en) | 1977-10-31 |
| DE1670952B2 (de) | 1975-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI49035C (fi) | Menetelmä terapeuttisesti käytettävän 2-bromi-alfa-ergokryptiinin valm istamiseksi. | |
| FI48062C (fi) | Menetelmä ksylitolin valmistamiseksi | |
| FI54301B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara kinazolinderivat | |
| FI51805C (fi) | Menetelmä allyyliasetaatin valmistamiseksi | |
| FI50421C (fi) | Analogiamenetelmä veren liikasokeripitoisuutta alentavien uusien sulfo nyylisemikarbatsidien valmistamiseksi | |
| FI47153C (fi) | Kiinteä seos steriloivan liuoksen valmistusta varten. | |
| FI48464C (fi) | Analogiamenetelmä veren sokeripitoisuutta alentavien sulfonyylivirtsa- ainejohdannaisten valmistamiseksi. | |
| FI49290C (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten benseenijohdannaiste n valmistamiseksi. | |
| FI49512C (fi) | Menetelmä uusien terapeuttisesti aktiivisten s-triatsinyylipiperatsiin ijohdannaisten valmistamiseksi. | |
| FI50334C (fi) | Menetelmä 1-hydroksi-2pyridonien valmistamiseksi. | |
| FI47365C (fi) | Menetelmä valmistaa uusia terapeuttisesti vaikuttavia indolijohdannais ia. | |
| FI48463C (fi) | Menetelmä veren sokerpitoisuutta alentavien bentsolisulfonyyli-virtsa- aineiden valmistamiseksi. | |
| FI47575C (fi) | Analogiamenetelmä evomonosidi-johdannaisten valmistamiseksi. | |
| FI45551C (fi) | Menetelmä terapeuttisesti käytettävän dehydroepiandrosteroniönantaatin valmistamiseksi. | |
| FI51182C (fi) | Menetelmä uusien verensokeria alentavien 2-bentseenisulfonamidopyrimid iinijohdannaisten valmistamiseksi. | |
| FI45957C (fi) | Menetelmä veren sokeripitoisuutta alentavien bentseenisulfonyylivirtsa -aineiden valmistamiseksi. | |
| FI45963C (fi) | Menetelmä veren sokeripitoisuutta alentavien bentseenisulfonyylivirtsa -aineiden valmistamiseksi. | |
| BG17471A3 (bg) | Центрофуга на специално за производство на захар | |
| FI50407C (fi) | Menetelmä trikloorimonosilaanien valmistamiseksi | |
| NL143109B (nl) | Werkwijze ter bereiding van p-nitrobenzeensulfonylisoureum bevattende preparaten ter verhoging van het suikergehalte van suikerriet. | |
| FI50975C (fi) | Menetelmä pyratsiiniamidi-johdannaisten valmistamiseksi. | |
| FI45964C (fi) | Menetelmä veren sokeripitoisuutta alentavien bentsolisulfonyylivirtsa- aineiden valmistamiseksi. | |
| FI47763C (fi) | Menetelmä uusien neriifoliini-johdannaisten valmistamiseksi. | |
| FI52088C (fi) | Menetelmä 3-(4-asyylioksialkyyli-1-piperatsinyyli)-karbonyylimetyyli-2 -bentsotiatsolinonijohdannaisten valmistamiseksi. | |
| FI46155C (fi) | Menetelmä veren sokeripitoisuutta alentavien bentseenisulfonyylivirtsa -aineiden valmistamiseksi. |